SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-09-002263
Filing Date
2009-09-24
Accepted
2009-09-24 11:00:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 zk97288.htm SC 13G 8288
  Complete submission text file 0001178913-09-002263.txt   10408
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 091083967
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 AZRIELI CENTER, ROUND TOWER,38TH FLOOR TEL AVIV L3 67021
Business Address 1 AZRIELI CENTER, ROUND TOWER,38TH FLOOR TEL AVIV L3 67021 972-3-7188700
Marathon Investments Ltd. (Filed by) CIK: 0001385788 (see all company filings)

IRS No.: 000000000
Type: SC 13G